BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Orexigen Therapeutics, Inc. 

48 Wall Street
Suite 1100
New York  New York  10005  U.S.A.
Phone: 212-918-4650 Fax: 212-918-4801


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Top Cardiologist Says Diet Drug Maker Orexigen (OREX) Misled Patients And Investors 5/13/2015 6:40:32 AM
Takeda (TKPYY) Threatens to End Orexigen (OREX) Partnership Over Stopped Obesity Study 5/13/2015 6:36:31 AM
Orexigen (OREX) Provides Statement On Termination Of The Light Study And Updates On Contrave Collaboration With Takeda Pharmaceuticals 5/13/2015 6:31:50 AM
Orexigen (OREX) Aborts Required Study For Diet Drug Contrave 5/12/2015 6:58:18 AM
Orexigen (OREX) To Speak At The Bank of America (BAC) Merrill Lynch Health Care Conference 5/11/2015 7:57:53 AM
Orexigen (OREX) Reports Financial And Business Results For The First Quarter Ended March 31, 2015 5/8/2015 11:13:37 AM
Orexigen (OREX) To Host First Quarter 2015 Financial Results Conference Call 5/5/2015 6:56:07 AM
Orexigen (OREX) Announces Receipt Of Paragraph IV Certification Notice 4/23/2015 12:40:16 PM
Orexigen (OREX) To Speak At The Needham Healthcare Conference 4/13/2015 7:06:10 AM
Orexigen (OREX) Announces That Tom Cannell Has Joined As Chief Commercial Officer 3/30/2015 9:00:47 AM
12345678910...